Concepedia

Aparna Balachandran

AB

Statistics

Publications

19

Citations

1.6K

H-Index

17

Active since

2010

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Aparna Balachandran is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, oncology, and pancreatic cancer.

Publications per year

2010–2017

19

Publications

19

Response of borderline resectable pancreatic cancer to neoadjuvant therapy is not reflected by radiographic indicators

Matthew H. G. Katz, Jason B. Fleming, Priya Bhosale et al. · Cancer · 2012 · 527 citations · Full text

, , +17

Serum carbohydrate antigen 19-9 represents a marker of response to neoadjuvant therapy in patients with borderline resectable pancreatic cancer

Ching‐Wei D. Tzeng, Aparna Balachandran, Mediha Ahmad et al. · HPB · 2013 · 174 citations · Full text

, , +13

Characterization of Anthropometric Changes that Occur During Neoadjuvant Therapy for Potentially Resectable Pancreatic Cancer

Amanda Cooper, Rebecca Slack, David R. Fogelman et al. · Annals of Surgical Oncology · 2014 · 157 citations · Full text

, , +14

Pathologic complete response to neoadjuvant therapy in patients with pancreatic ductal adenocarcinoma is associated with a better prognosis

Qing Zhao, Asif Rashid, Yun Gong et al. · Annals of Diagnostic Pathology · 2011 · 127 citations

, , +10

Defined Clinical Classifications Are Associated with Outcome of Patients with Anatomically Resectable Pancreatic Adenocarcinoma Treated with Neoadjuvant Therapy

Ching‐Wei D. Tzeng, Jason B. Fleming, Jeffrey E. Lee et al. · Annals of Surgical Oncology · 2012 · 109 citations

, , +14

1–5 of 19